Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer

L.H.A.M. de Wilt; G. Jansen; Y.G. Assaraf; J. van Meerloo; J. Cloos; A.D. Schimmer; E.T. Chan; C.J. Kirk; G.J. Peters; F.A. Kruyt

doi:https://doi.org/10.1016/j.bcp.2011.10.009

Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer

L.H.A.M. de Wilt, G. Jansen, Y.G. Assaraf, J. van Meerloo, J. Cloos, A.D. Schimmer, E.T. Chan, C.J. Kirk, G.J. Peters, F.A. Kruyt

Research output: Contribution to journal › Article › Academic › peer-review

59 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	207-217
Journal	Biochemical Pharmacology
Volume	83
Issue number	2
DOIs	https://doi.org/10.1016/j.bcp.2011.10.009
Publication status	Published - 2012

Access to Document

https://doi.org/10.1016/j.bcp.2011.10.009

Cite this

@article{85d411bdbafe44478fc2d9f723f86c0e,

title = "Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer",

author = "{de Wilt}, L.H.A.M. and G. Jansen and Y.G. Assaraf and {van Meerloo}, J. and J. Cloos and A.D. Schimmer and E.T. Chan and C.J. Kirk and G.J. Peters and F.A. Kruyt",

year = "2012",

doi = "https://doi.org/10.1016/j.bcp.2011.10.009",

language = "Undefined/Unknown",

volume = "83",

pages = "207--217",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer

AU - de Wilt, L.H.A.M.

AU - Jansen, G.

AU - Assaraf, Y.G.

AU - van Meerloo, J.

AU - Cloos, J.

AU - Schimmer, A.D.

AU - Chan, E.T.

AU - Kirk, C.J.

AU - Peters, G.J.

AU - Kruyt, F.A.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.1016/j.bcp.2011.10.009

DO - https://doi.org/10.1016/j.bcp.2011.10.009

M3 - Article

C2 - 22027222

SN - 0006-2952

VL - 83

SP - 207

EP - 217

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

IS - 2

ER -